Biotech company gets €1m funding
A spin-out from the Stokes Research Institute at the University of Limerick, Stokes Bio Limited develops microfluidics-based diagnostic systems for the genetic diagnosis of cancer.
Childhood leukaemia is the initial target disease around which the microfluidics based platform technology is developed.





